News | Cardiovascular Ultrasound | December 21, 2017

Bay Labs Completes $5.5 Million Series A Financing for AI-Driven Ultrasound

Funding will be used to accelerate clinical validation, technological development and U.S. market commercialization

Bay Labs Completes $5.5 Million Series A Financing for AI-Driven Ultrasound

December 21, 2017 — Bay Labs, a medical technology company applying artificial intelligence (AI) to cardiovascular imaging, recently announced it completed $5.5 million in financing. The Series A round was led by existing investor Khosla Ventures with participation from new investors including Data Collective (DCVC), Greenbox Venture Partners, Minneapolis Heart Institute Ventures and Georges Harik. Proceeds will be used to continue clinical validation, accelerate technological development and bring Bay Labs’ products to the U.S. market. In addition, Ben Ling, general partner at Khosla Ventures, and Armen Vidian, operating partner at DCVC, will join Bay Labs’ board of directors.

Physicians today need imaging studies that provide high-quality diagnostic capabilities no matter where the patient is, from the inpatient hospital setting to the outpatient and point of care settings. Bay Labs applies AI to cardiovascular imaging to help in the diagnosis and management of heart disease. An echocardiographic exam is the gateway to cardiovascular disease diagnosis and a key to disease management and appropriate timing of intervention. The company’s deep learning technology, a type of AI algorithm, is designed to help medical professionals of all skill levels perform and interpret echocardiograms and may improve the treatment of heart diseases. Bay Labs has partnered with the Minneapolis Heart Institute and Allina Health, Northwestern Medicine, Duke University School of Medicine and cardiologists at Stanford University to develop, test and validate deep learning algorithms for echocardiography.

“Bay Labs' unique application of AI with ultrasound has the potential to enable medical professionals to provide faster and better care to patients,” said Ben Ling, general partner at Khosla Ventures.  “We are excited to increase our investment in Bay Labs to revolutionize ultrasound.”

“We are impressed with the strength of the Bay Labs AI engine to bring consistently high-quality ultrasound images and key data to physicians when they need it most – at the point of care, and we are especially excited to see such early enthusiasm from some of the world’s leading physicians,” said Armen Vidian, operating partner at DCVC. “We see tremendous potential for this intelligent, data-rich technology to impact how and when physicians direct patient care to dramatically improve outcomes.”

For more information: www.baylabs.io

 

Related Content

Artificial Intelligence Advances Threaten Privacy of Health Data
News | Artificial Intelligence | January 04, 2019
Advances in artificial intelligence (AI) have created new threats to the privacy of people's health data, a new...
Videos | Artificial Intelligence | December 12, 2018
This is a quick video tour of the Machine Learning Showcase at the ...
Bay Labs Collaborating With Edwards Lifesciences on AI for Heart Disease Detection
News | Artificial Intelligence | December 10, 2018
Medical artificial intelligence (AI) company Bay Labs announced a collaboration with Edwards Lifesciences focused on...
An example of artificial intelligence-aided clinical decision support software for a heart failure patient from the vendor HealthReveal. The AI pulled in relevant patient data from the electronic medical record and offers recommendations for care based on current American Heart Association (AHA) guidelines. It also offers the citations for where to find the guidelines and prescribing information for the recommended drug. Machine learning for cardiology.

An example of artificial intelligence-aided clinical decision support software for a heart failure patient from the vendor HealthReveal. The AI pulled in relevant patient data from the electronic medical record and offers recommendations for care based on current American Heart Association (AHA) guidelines. It also offers the citations for where to find the guidelines and prescribing information for the recommended drug.

Feature | Artificial Intelligence | December 06, 2018 | Lonny Reisman, M.D.
The consistent provision of guideline-directed medical therapy (GDMT) — care delivered according to established guide
AI Predicts Cardiovascular Disease Risk From CT Scans
News | Artificial Intelligence | November 27, 2018
November 27, 2018 – Zebra Medical Vision and Clalit Health Services announced the completion of a research project th
AI Algorithm Outperforms Most Cardiologists in Heart Murmur Detection
News | Artificial Intelligence | November 11, 2018
At the American Heart Association’s (AHA) Scientific Sessions 2018, Nov. 10-12 in Chicago, Eko presented a clinical...
Overlay Init